With the analysis among 197 patents, we discovered top 49 key players by total patent application. ViroNovative BV, MedImmune LLC, Enanta Pharmaceuticals, Inc. are dominant in this area. They take 50.76% of the total patent filing.
Gelderland, Netherlands
Patent: 41
Louisiana, United States
Patent: 35
Massachusetts, United States
Patent: 24
Centre National De La Recherche Scientif
Georgia, United States
Patent: 14
Hokkaido, Japan
Patent: 14
Georgia, United States
Patent: 10
New York, United States
Patent: 8
Shanghai Shi, China
Patent: 8
With the analysis among 17 patents, we discovered top 1 start-ups by total patent application.
With the analysis among related 120 patents applied in the last 5 years. We discover 46 most active companies in this area. The fast-growing Enanta Pharmaceuticals, Inc., Centre National De La Recherche Scientif, Université Laval take 50.83% of patent filing during this period.
Massachusetts, United States
Patent: 24
Centre National De La Recherche Scientif
Shanghai Shi, China
Patent: 8
Alabama, United States
Patent: 7
Sichuan Sheng, China
Patent: 4
With the analysis among related 120 patents in last 5 years, we discover 37 new entrants. Enanta Pharmaceuticals, Inc., Centre National De La Recherche Scientif, Institut National de la Santé et de la Recherche Médicale are the most active new entrants in this area.
Massachusetts, United States
Patent: 24
Centre National De La Recherche Scientif
Shanghai Shi, China
Patent: 8
Sichuan Sheng, China
Patent: 4
New York, United States
Patent: 2
Missouri, United States
Patent: 2
With the analysis among 155 patents, we discovered top 21 universities and scientific research institutions by total patent application. Pontificia Universidad Católica de Chile, Université Laval, Université Claude Bernard Lyon 1 are dominant in this area. They take 66.45% of the total patent filing.
Tennessee, United States
Patent: 9
California, United States
Patent: 5
Queensland, Australia
Patent: 3
Seneca College of Applied Arts & Technology
New Mexico, United States
Patent: 2